Comments
Generic drugmaker Ajanta Pharma's shares have risen as much as 3.8 percent to ₹915, the biggest daily percentage gain since July 16.
The company has posted 8.5 percent jump in June-quarter profit to ₹115 crore ($16.64 million) and the revenue increased 19.7 percent to ₹612 crore.
It has registered an export sales up 25 percent, while U.S. generic sales have risen 67 percent.
Up to the last close, the stock had fallen 26 percent this year, while peer Procter & Gamble Health Ltd up 69 percent.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.